Emerson Electric Company (EMR)
Official siteINDUSTRIALS • SPECIALTY INDUSTRIAL MACHINERY • NYSE
Market Cap: $91.28B
Last updated: Nov 17, 2026 at 11:05 AM ET
Emerson Electric Company (EMR) Stock Forecast
Analysts expect Emerson Electric Company (EMR) to earn $7.31 per share in the fiscal year ending Sep 30, 2027, on revenue of $20.00B. Of 30 analysts, 20 rate the stock Buy or Strong Buy, 8 Hold and 2 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Sep 30, 2028, the EPS consensus is $8.03.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 30 ratings average 2.27, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 67% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 13.3% |
| Buy | 16 | 53.3% |
| Hold | 8 | 26.7% |
| Sell | 2 | 6.7% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 30
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.8% and revenue estimates rise 5.3%.
- Fiscal year ending Sep 30, 2027
- $7.31
- EPS consensus, revenue $20.00B
- Fiscal year ending Sep 30, 2028
- $8.03
- EPS consensus, revenue $21.05B
- Next report
- Feb 1, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | $7.31 | $7.25 to $7.47 | 28 | $20.00B | $19.84B to $20.31B | 27 |
| Sep 30, 2028 | $8.03 | $7.34 to $8.44 | 26 | $21.05B | $20.50B to $21.77B | 25 |
Quarterly Estimates
The EPS consensus rises from $1.62 for the quarter ending Dec 31, 2026 to $1.73 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.62 | $1.58 to $1.71 | 22 | $4.59B | $4.56B to $4.71B | 20 |
| Mar 31, 2027 | $1.73 | $1.67 to $1.83 | 21 | $4.85B | $4.77B to $4.95B | 19 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 23 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2028 | 6 | 6 |
| Quarter ending Dec 31, 2026 | 0 | 8 |
| Quarter ending Mar 31, 2027 | 1 | 9 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has risen 1.0% from $7.24.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | $7.31 | $7.31 | $7.27 | $7.25 | $7.24 | +1.0% |
| Fiscal year ending Sep 30, 2028 | $8.03 | $8.02 | $8.03 | $8.03 | $8.01 | +0.2% |
| Quarter ending Dec 31, 2026 | $1.62 | $1.63 | $1.63 | $1.62 | $1.61 | +0.5% |
| Quarter ending Mar 31, 2027 | $1.73 | $1.73 | $1.74 | $1.73 | $1.72 | +0.6% |
Frequently Asked Questions About EMR
What is the EMR stock forecast?
Consensus analyst estimates put Emerson Electric Company's EPS at $7.31 for the fiscal year ending Sep 30, 2027, on revenue of $20.00B. The consensus rating from 30 analysts is Buy.
How do analysts rate EMR stock?
Of 30 analysts covering Emerson Electric Company, 4 rate it Strong Buy, 16 Buy, 8 Hold, 2 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from EMR next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is $7.31, with estimates from $7.25 to $7.47 from 28 analysts. For the fiscal year ending Sep 30, 2028, the consensus EPS estimate is $8.03, with estimates from $7.34 to $8.44 from 26 analysts.
What revenue do analysts expect from Emerson Electric Company next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $20.00B, with estimates from $19.84B to $20.31B. For the fiscal year ending Sep 30, 2028, the consensus revenue estimate is $21.05B, with estimates from $20.50B to $21.77B.
How many analysts cover EMR?
30 analysts rate Emerson Electric Company stock, and 28 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
EMR pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts